Outsourcing

CMO industry consolidation may be frustrated by a dearth of attractive assets.

As 3-D screening and lab automation improve lead optimization, open collaborative models are breaking down long-established walls. Will the industry redefine the way it handles R&D?

Ash Stevens has received FDA’s approval to manufacture Takeda’s multiple myeloma drug, ixazomib, at its facility in Riverview, Michigan.

The University of Sheffield has appointed Cobra Biologics to advance novel fusion protein technology into Phase 1 clinical trials.

Expansions at Catalent’s Kansas City, MO, and Madison, WI facilities made in response to industry demand.

Operations at Catalent’s Beinheim, France, softgel facility were suspended following suspected deliberate action to misplace capsules.

The UK’s National Biologics Manufacturing Centre will use Novasep’s BioSC Lab for protein purification.

Industry veteran Mark Kontny joins board of directors at Grand River Aseptic Manufacturing.

Biotech boom, niche markets, smaller batch sizes and high potency manufacturing are among the key trends shaping the pharmaceutical industry of the 21st century, according to Christian Treitel from Bosch Packaging Technology.

Better process development is creating industry benchmarks for bioprocessing.

While biologics development grabs investor interest, small-molecule APIs still hold two-thirds of the drug-development pipeline.

CDMO Xcelience opens new facility in Tampa, FL, for formulation and analytical services.

New instrumentation at the SGS Mississauga, Canada facility advances testing capabilities for packaging and container testing.

Closing the summer of 2015, the ChemOutsourcing conference examined contract services from both a sponsor’s and a CMO or CRO’s perspective

The two companies will combine life-sciences marketing and a consulting firm to create a life sciences-centered consulting service.

Scottish injectable-drug manufacturer Symbiosis Pharmaceutical Services plans to expand its sterile filling facility.

CDMO Aesica Pharmaceuticals introduced a new service approach in which the company will taks on the management of other CDMOs, while serving as the single, central point of customer contact, the company announced in an Oct. 14, 2015 press release.

In the past, contract manufacturing organizations (CMOs) and contract development manufacturing organizations (CDMOs) have been focused most on achieving scale, reaching new clients in new geographic regions, and adding services that were previously unavailable, according to Gil Y. Roth, president of the Pharma and Biopharma Outsourcing Association. In a new report from CPhI, Roth explicates how consolidation has changed how CMOs position their services to clients and how CMOs add value to their businesses.

Upgrades to Mettler Toledo’s weighing and dosing equipment increase productivity using lean laboratory principles.

Cell Therapy Catapult will provide manufacturing scale-up services to enable Asterias’ future clinical trials and commercial supply for Asterias’ allogeneic dendritic cell immunotherapy, AST-VAC2.

Contract manufacturer PiazaBio announces services for Western Pharma companies seeking to enter the China market.

Merck Millipore’s collaboration with celares GmbH launches pegylation services for protein-based therapeutics.

Despite emergence of biologics, small-molecule APIs benefit from industry growth.

Vetter plans to invest approximately 300 million Euros during the course of five years to expand drug product manufacturing and logistic services in Germany; upgrades will include an improved RABS system for aseptic processing.

Sterigenics International will triple West Memphis sterilization capacity with $15 million expansion.

The Grünenthal Group’s Tecnandina manufacturing plant in Ecuador has received the country’s first certification from the Regulatory Authority of Brazil.

The CDMO is striving to become a market leader in the development and manufacturing of antibody-drug conjugates.

Pharma development and manufacturing firm Patheon announces new tagline and logo.

Cobra Biologics and the University of Manchester announce a collaboration to improve industrial scale-up of mammalian cell bioprocessing.

Abenza acquired biopharmaceutical CDMO PacificGMP and expanded the company’s San Diego facility.